Federal award (DELIVERY ORDER, fiscal year 2023)
Recipient: WESTAT, INC.
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2024-03-01 to 2029-02-28
Current total value of award: $2505456
Description: THE PURPOSE OF THIS TO IS TO RECRUIT, FOLLOW, AND COMPLETE THE "OPEN-LABEL, PHASE I STUDY OF THE SAFETY AND PHARMACOKINETICS OF PGT121.414.LS ALONE AND IN COMBINATION WITH VRC07-523LS IN INFANTS EXPOSED TO HIV-1."